Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Share News (VAL)

Share Price Information for ValiRx (VAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.25
Bid: 3.20
Ask: 3.30
Change: 0.00 (0.00%)
Spread: 0.10 (3.125%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3.25
VAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

CORRECT: AIM IN BRIEF: Herstal Emerges As Favourite To Acquire Manroy

Thu, 28th Nov 2013 12:27

(Correcting headline to refer to Herstal.)

LONDON (Alliance News) - The following AIM-listed companies are making headlines on Alliance News Professional at the market open Thursday:
--------
Mar City To Buy Eight Plots Of Land For About GBP30.8M; Launches GBP25.8M Placing
----------
NewRiver Retail To Buy 202 Pubs From Marston's For GBP90M; To Convert All Pubs To Other Uses; Buys Two Retail Centres For GBP34.3M; H1 Pretax Profit GBP5.2M Vs GBP479,000; Keeps Interim Dividend At 6.0P
----------
Idox Wins USD1.5M Contract With Unamed Canadian Oil & Gas Co.
----------
Plethora Solutions Says CEO Ronald Openshaw To Step Down; Says Non-Exec Director Mike Collis To Act As CFO; Says Intends To Further Strengthen Management Team
----------
Digital Barriers H1 Pretax Loss GBP7.2M Vs GBP7.1M Loss; Revenue GBP9M Vs GBP8.1M; Appoints New Finance Director
----------
Triple Plate Junction H1 Pretax Loss GBP234K Vs GBP320K; Spent GBP52,000 During The Period On Possible Transactions
----------
Brightside Appoints Paul Williams As New CEO From Early 2014
----------
Manroy Says Has Ended Takeover Talks With U.S. Ordnance But Still Talking With Herstal And Beretta; Says In "Active Discussions" With Herstal; Says Beretta Talks Not Active But Not Terminated
----------
Hummingbird Says Results Confirm Confidence On Tuzon Deposit; To Commence Additional Drilling At Site
----------
M&C Saatchi Agrees To Sell 75.1% Of Walker Media To Publicis Groupe For GBP36M In Cash; Will Retain 24.9% Of Walker Media And Have Right To Appoint Directors
----------
Leni Gas & Oil Says Plans To Drill First New Wells At Goudron Progress; Working With Authorities To Get Final Approvals
----------
Sigma Capital Agrees GBP700M Joint Venture With Gatehouse Bank For UK Privately Rented Residential Properties; JV To Build Initial 2,000 New Rental Homes In 22 Sites In North West Of England; JV Provides For Development Of 4,600 Additional New Rented Homes
----------
Publishing Technology: FY Results To Be Below Expectations Due To Delayed Completion Of Projects; Outlook For 2014 Remains A Steady Improvement
----------
Character Group FY Pretax Profit GBP0.72M Vs GBP7.1M; FY Sales GBP67.2M Vs GBP74.95M; Keeps Final Dividend At 3.30P; Says Saw A Turnaround In H2; Expects Substantially Better Results In 2014
----------
Ceramic Fuel Cells Sells 1,000 BlueGEN Units To Baltic Distributor For Over EUR20M
----------
Legendary Investments Says Virtualstock Limited Has Successfully Implemented Its System With Tesco
----------
Impax Asset Management FY Pretax profit GBP3.4M Vs GBP4.7M Loss; FY Revenue GBP18.5M Vs GBP18.6M
----------
Peninsular Gold FY Pretax Profit GBP2.3M Vs GBP3.0M; Rev From Unhedged Gold Sales GBP22.8M Vs GBP18.7M; Produced 5,836 Ounces Of Gold For Quarter July To Sept 2013
----------
Inland Home Signs Agreement With Defence Infrastructure Organisation For Wilton Park In Beaconsfield
----------
Pilat Media Q3 Profit After Tax GBP32,000 Vs GBP20,000 Loss; Revenue GBP6.29M Vs GBP5.31M; Says Strong Q4 To Results In Strong FY Revenue, Profit Growth
----------
ValiRx Says Has Received More Positive Studies On VAL201
----------
James Latham H1 Pretax Profit GBP4.2M Vs GBP4.1M; Rev GBP82.2M Vs GBP74.9M; Increases Interim Dividend To 3.4P Vs 3.1P
----------
Mercom Oil Sands Reaches Settlement With Nordic Petroleum On Chard Oil Sands Leases; Mercom Oil Sands To Pay Undisclosed Cash Sum, 13M New Shares
----------
Thor Mining Chairman: Challenges Ahead Are Securing Funds, Completing Upgrade To Molyhill Project; On Track To Increase Interest In Spring Hill To 80% By January 31 2014
----------
Mining Investments Resources FY Loss GBP368,000 Vs GBP634,000
----------
All Asia Asset Capital Buys Minority Stake In Myanmar Allure Group
--------
Copyright 2013 Alliance News Limited. All Rights Reserved.

More News
9 Jan 2019 14:57

ValiRx gives NHS Long Term Plan its seal of approval

(Sharecast News) - Clinical stage biotechnology company ValiRx endorsed the Government's new NHS Long Term Plan to improve the quality of patient care and health outcomes on Wednesday.

Read more
9 Jan 2019 11:25

ValiRx Backs New Long-Term UK Government Plan For NHS

LONDON (Alliance News) - Biotechnology firm ValiRx PLC on Wednesday said it endorses the UK government's new NHS long-term plan."The government's recently announced ten-year a

Read more
18 Dec 2018 15:53

VAL401 results accepted for journal publication, says ValiRx

(Sharecast News) - Clinical stage biotechnology company ValiRx announced the acceptance for publication of the first article containing results from the VAL401 clinical trial by the European Journal of Drug Metabolism and Pharmacokinetics on Tuesday.

Read more
10 Dec 2018 11:07

ValiRx releases positive data from recent VAL201 testing

(Sharecast News) - Clinical stage biotechnology company ValiRx announced on Monday that independent analysis of VAL201 data showed a "statistically significant" dose dependant response in the reduction of PSA correlated to time on the Phase l/ll clinical trial, involving patients with hormone-sensitive and hormone-resistant prostate cancer.

Read more
10 Dec 2018 10:59

WINNERS & LOSERS SUMMARY: Just Group Jumps 23% On Regulatory Decision

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - WINNERS----------NMC up The

Read more
10 Dec 2018 09:06

ValiRx Reports Positive VAL201 Effect On Patients With Prostate Cancer

LONDON (Alliance News) - ValiRx PLC on Monday said an independent analysis of VAL201 showed a positive effect on patients with hormone-sensitive and hormone-resistant prostate cancer.The up

Read more
17 Oct 2018 08:36

ValiRx enters finals stages of clinical trials on VAL201

(Sharecast News) - Clinical stage biotechnology company ValiRx's leading anti-cancer therapeutic has entered the concluding stages of its Phase l/ll clinical trial at University College London Hospital.

Read more
25 Sep 2018 13:23

ValiRx Half Year Loss Widens On Expenses And Share Option Charge

LONDON (Alliance News) - Life science company ValiRx PLC on Tuesday reported a widened loss in the first half of 2018 due to expenses and a sizeable share option charge.The company's to

Read more
6 Sep 2018 11:38

ValiRx Says Clinical Study For Lung Cancer Drug VAL401 Is Approved

LONDON (Alliance News) - Clinical stage biotechnology company ValiRx PLC said Thursday its clinical study report on lung cancer drug VAL401 has been signed and approved by principal in ValiRx were

Read more
6 Sep 2018 09:05

ValiRx enters 'very exciting' phase for cancer therapies

(Sharecast News) - ValiRx told investors on Thursday that its clinical-stage therapeutics had continued to demonstrate "significant potential" for addressing unmet medical needs in oncology.

Read more
14 Jun 2018 11:00

WINNERS & LOSERS SUMMARY: Rolls Royce Flies High With Planned Job Cuts

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Thursday.----------FTSE 100 - up 2.6%. The jet engine maker said it will cut

Read more
11 May 2018 16:43

Nicholas Slater Increases ValiRx Stake To 4.5% From 2.7% (ALLISS)

LONDON (Alliance News) - ValiRx PLC said Friday Nicholas Slater had almost doubled his stake in life science company, which focuses on cancer treatments, to 4.5% after a transaction on raised his

Read more
4 May 2018 17:08

ValiRx Raises GBP950,000 Through Placing To Progress Pipeline (ALLISS)

LONDON (Alliance News) - ValiRx PLC said Friday it has raised GBP950,000 through the issue of 47.5 million shares at 2.00 pence per share.The clinical stage biotechnology company's down

Read more
25 Apr 2018 13:41

"Major" Milestone As ValiRx's VAL201 Is Granted Patent In EU

LONDON (Alliance News) - Biotechnology company ValiRx PLC said Wednesday its VAL201 compound has been granted a patent in the EU.This, it said, follows a US patent which was granted for a a

Read more
19 Apr 2018 12:41

ValiRx Posts Positive Results From VAL101 Compound Pre-Clinical Trials

LONDON (Alliance News) - ValiRx PLC on Thursday said pre-clinical studies showed that its VAL101 compund has a potential to prevent cancer growth at cellular biochemical and genomic molecule is is

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.